Skip to main content
Top
Published in: Infection 6/2022

Open Access 10-05-2022 | Transesophageal Echocardiography | Original Paper

Enterococcus faecalis bacteremia, cardiac implantable electronic device, extraction, and the risk of recurrence

Authors: Andreas Berge, Ludvig Arkel, Bo Nilson, Magnus Rasmussen

Published in: Infection | Issue 6/2022

Login to get access

Abstract

Purpose

In all patients with cardiac implantable electronic devices (CIED) and Enterococcus faecalis bacteremia (EfsB), endocarditis (IE) and CIED infection should be suspected. Guidelines recommend extraction of the CIED when CIED infection or IE is diagnosed. Whether extraction of the CIED should be done in other situations with EfsB is not known. We aimed to describe the management and outcome of patients with CIED and monomicrobial EfsB, in relation to extraction and recurrent EfsB.

Methods

A population-based cohort of patients with monomicrobial EfsB from January 2014 to November 2020 was identified through microbiology registers in the Region Skåne, Sweden. Data on CIED and other clinical features were collected from medical records.

Results

Among 1087 episodes of EfsB, 72 patients with CIED and monomicrobial EfsB were identified. Five of these patients were diagnosed with IE (7%), three of whom had echocardiographic changes on the CIED. Four CIED were extracted (6%). Recurrences were found in seven of 68 patients (10%) not subjected to extraction and in none of the extracted. In the group of patients without extraction, community acquisition and predisposition for IE were significantly associated with recurrent infection in univariate analyses. No infections involving the CIED were diagnosed during the recurrences.

Conclusions

In patient with monomicrobial EfsB, it seems safe to omit extraction if no structural changes are found on the CIED.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851–9.CrossRefPubMed Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851–9.CrossRefPubMed
2.
go back to reference Hussein AA, Baghdy Y, Wazni OM, et al. Microbiology of cardiac implantable electronic device infections. JACC Clin Electrophysiol. 2016;2:498–505.CrossRefPubMed Hussein AA, Baghdy Y, Wazni OM, et al. Microbiology of cardiac implantable electronic device infections. JACC Clin Electrophysiol. 2016;2:498–505.CrossRefPubMed
3.
go back to reference Blomström-Lundqvist C, Traykov V, Erba PA, et al. European heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the heart rhythm society (HRS), the Asia Pacific heart rhythm society (APHRS), the Latin American heart rhythm society (LAHRS), international society for cardiovascular infectious diseases (ISCVID) and the European society of clinical microbiology and infectious diseases (ESCMID) in collaboration with the European association for cardio-thoracic surgery (EACTS). Eur J Cardiothorac Surg. 2020;57:e1–31.CrossRefPubMed Blomström-Lundqvist C, Traykov V, Erba PA, et al. European heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the heart rhythm society (HRS), the Asia Pacific heart rhythm society (APHRS), the Latin American heart rhythm society (LAHRS), international society for cardiovascular infectious diseases (ISCVID) and the European society of clinical microbiology and infectious diseases (ESCMID) in collaboration with the European association for cardio-thoracic surgery (EACTS). Eur J Cardiothorac Surg. 2020;57:e1–31.CrossRefPubMed
4.
go back to reference Oh TS, Le K, Baddour LM, et al. Cardiovascular implantable electronic device infections due to enterococcal species: clinical features, management, and outcomes. Pacing Clin Electrophysiol. 2019;42:1331–9.CrossRefPubMed Oh TS, Le K, Baddour LM, et al. Cardiovascular implantable electronic device infections due to enterococcal species: clinical features, management, and outcomes. Pacing Clin Electrophysiol. 2019;42:1331–9.CrossRefPubMed
5.
go back to reference Olmos C, Vilacosta I, Fernández-Pérez C, et al. The evolving nature of infective endocarditis in Spain: a population-based study (2003–2014). J Am Coll Cardiol. 2017;70:2795–804.CrossRefPubMed Olmos C, Vilacosta I, Fernández-Pérez C, et al. The evolving nature of infective endocarditis in Spain: a population-based study (2003–2014). J Am Coll Cardiol. 2017;70:2795–804.CrossRefPubMed
6.
go back to reference Fernández-Guerrero ML, Herrero L, Bellver M, Gadea I, Roblas RF, de Górgolas M. Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia. J Intern Med. 2002;252:510–5.CrossRefPubMed Fernández-Guerrero ML, Herrero L, Bellver M, Gadea I, Roblas RF, de Górgolas M. Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia. J Intern Med. 2002;252:510–5.CrossRefPubMed
7.
go back to reference Bouza E, Kestler M, Beca T, et al. The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. Clin Infect Dis. 2015;60:528–35.CrossRefPubMed Bouza E, Kestler M, Beca T, et al. The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. Clin Infect Dis. 2015;60:528–35.CrossRefPubMed
8.
go back to reference Dahl A, Lauridsen TK, Arpi M, et al. Risk factors of endocarditis in patients with enterococcus faecalis bacteremia: external validation of the NOVA score. Clin Infect Dis. 2016;63:771–5.CrossRefPubMed Dahl A, Lauridsen TK, Arpi M, et al. Risk factors of endocarditis in patients with enterococcus faecalis bacteremia: external validation of the NOVA score. Clin Infect Dis. 2016;63:771–5.CrossRefPubMed
9.
go back to reference Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore). 1988;67:248–69.CrossRefPubMed Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore). 1988;67:248–69.CrossRefPubMed
10.
go back to reference Dahl A, Iversen K, Tonder N, et al. Prevalence of infective endocarditis in enterococcus faecalis bacteremia. J Am Coll Cardiol. 2019;74:193–201.CrossRefPubMed Dahl A, Iversen K, Tonder N, et al. Prevalence of infective endocarditis in enterococcus faecalis bacteremia. J Am Coll Cardiol. 2019;74:193–201.CrossRefPubMed
11.
go back to reference Berge A, Krantz A, Ostlund H, Naucler P, Rasmussen M. The DENOVA score efficiently identifies patients with monomicrobial enterococcus faecalis bacteremia where echocardiography is not necessary. Infection. 2019;47:45–50.CrossRefPubMed Berge A, Krantz A, Ostlund H, Naucler P, Rasmussen M. The DENOVA score efficiently identifies patients with monomicrobial enterococcus faecalis bacteremia where echocardiography is not necessary. Infection. 2019;47:45–50.CrossRefPubMed
12.
go back to reference Oldberg K, Rasmussen M. Enterococcus faecalis in blood cultures-a prospective study on the role of persistent bacteremia. Diagn Microbiol Infect Dis. 2021;101: 115433.CrossRefPubMed Oldberg K, Rasmussen M. Enterococcus faecalis in blood cultures-a prospective study on the role of persistent bacteremia. Diagn Microbiol Infect Dis. 2021;101: 115433.CrossRefPubMed
13.
go back to reference Oldberg K, Thorén R, Nilson B, Gilje P, Inghammar M, Rasmussen M. Short time to blood culture positivity in enterococcus faecalis infective endocarditis. Eur J Clin Microbiol Infect Dis. 2021;40:1657–64.CrossRefPubMedPubMedCentral Oldberg K, Thorén R, Nilson B, Gilje P, Inghammar M, Rasmussen M. Short time to blood culture positivity in enterococcus faecalis infective endocarditis. Eur J Clin Microbiol Infect Dis. 2021;40:1657–64.CrossRefPubMedPubMedCentral
14.
go back to reference Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American heart association. Circulation. 2015;132:1435–86.CrossRefPubMed Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American heart association. Circulation. 2015;132:1435–86.CrossRefPubMed
15.
go back to reference Sandoe JA, Barlow G, Chambers JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint working party project on behalf of the British society for antimicrobial chemotherapy (BSAC, host organization), British heart rhythm society (BHRS), British cardiovascular society (BCS), British heart valve society (BHVS) and British society for echocardiography (BSE). J Antimicrob Chemother. 2015;70:325–59.CrossRefPubMed Sandoe JA, Barlow G, Chambers JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint working party project on behalf of the British society for antimicrobial chemotherapy (BSAC, host organization), British heart rhythm society (BHRS), British cardiovascular society (BCS), British heart valve society (BHVS) and British society for echocardiography (BSE). J Antimicrob Chemother. 2015;70:325–59.CrossRefPubMed
16.
go back to reference Sohail MR, Palraj BR, Khalid S, et al. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015;8:137–44.CrossRefPubMed Sohail MR, Palraj BR, Khalid S, et al. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015;8:137–44.CrossRefPubMed
17.
go back to reference Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.CrossRefPubMed Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.CrossRefPubMed
18.
go back to reference Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis. Recommendations by the American heart association. JAMA. 1990;264:2919–22.CrossRefPubMed Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis. Recommendations by the American heart association. JAMA. 1990;264:2919–22.CrossRefPubMed
19.
go back to reference George MP, Esquer Garrigos Z, Vijayvargiya P, et al. Discriminative ability and reliability of transesophageal echocardiography in characterizing cases of cardiac device-lead vegetations versus non-infectious echodensities. Clin Infect Dis. 2020;72:1938–43.CrossRef George MP, Esquer Garrigos Z, Vijayvargiya P, et al. Discriminative ability and reliability of transesophageal echocardiography in characterizing cases of cardiac device-lead vegetations versus non-infectious echodensities. Clin Infect Dis. 2020;72:1938–43.CrossRef
20.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
21.
go back to reference Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–82.CrossRefPubMed Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–82.CrossRefPubMed
22.
go back to reference Habib G, Lancellotti P, Antunes MJ, et al. ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC). Endorsed by: European association for cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM). Eur Heart J. 2015;36:3075–128.CrossRefPubMed Habib G, Lancellotti P, Antunes MJ, et al. ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC). Endorsed by: European association for cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM). Eur Heart J. 2015;36:3075–128.CrossRefPubMed
23.
go back to reference Palraj BR, Baddour LM, Hess EP, et al. Predicting risk of endocarditis using a clinical tool (PREDICT): scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2015;61:18–28.CrossRefPubMedPubMedCentral Palraj BR, Baddour LM, Hess EP, et al. Predicting risk of endocarditis using a clinical tool (PREDICT): scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2015;61:18–28.CrossRefPubMedPubMedCentral
24.
go back to reference Tubiana S, Duval X, Alla F, et al. The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. J Infect. 2016;72:544–53.CrossRefPubMed Tubiana S, Duval X, Alla F, et al. The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. J Infect. 2016;72:544–53.CrossRefPubMed
25.
go back to reference Friedman ND, Kaye KS, Stout JE, et al. Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–7.CrossRefPubMed Friedman ND, Kaye KS, Stout JE, et al. Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–7.CrossRefPubMed
26.
go back to reference Bizzini A, Durussel C, Bille J, Greub G, Prod’hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol. 2010;48:1549–54.CrossRefPubMedPubMedCentral Bizzini A, Durussel C, Bille J, Greub G, Prod’hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol. 2010;48:1549–54.CrossRefPubMedPubMedCentral
27.
go back to reference Sonesson A, Öqvist B, Hagstam P, Björkman-Burtscher IM, Miörner H, Petersson AC. An immunosuppressed patient with systemic vasculitis suffering from cerebral abscesses due to Nocardia farcinica identified by 16S rRNA gene universal PCR. Nephrol Dial Transplant. 2004;19:2896–900.CrossRefPubMed Sonesson A, Öqvist B, Hagstam P, Björkman-Burtscher IM, Miörner H, Petersson AC. An immunosuppressed patient with systemic vasculitis suffering from cerebral abscesses due to Nocardia farcinica identified by 16S rRNA gene universal PCR. Nephrol Dial Transplant. 2004;19:2896–900.CrossRefPubMed
Metadata
Title
Enterococcus faecalis bacteremia, cardiac implantable electronic device, extraction, and the risk of recurrence
Authors
Andreas Berge
Ludvig Arkel
Bo Nilson
Magnus Rasmussen
Publication date
10-05-2022
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2022
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-022-01838-3

Other articles of this Issue 6/2022

Infection 6/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.